Antiproliferative efficacy of lipophilic soy isoflavone phytoestrogens delivered by low density lipoprotein particles into cultured U937 cells.
Some fat-soluble bioactive substances incorporated into low density lipoprotein (LDL) may be delivered into cells via LDL receptor pathway influencing cellular functions. In this study, we synthesized a number of fat-soluble isoflavone esters and investigated their incorporation into LDL as well as their delivery into U937 cells. Using an artificial transfer system (Celite dispersion), genistein and daidzein oleates and daidzein dilinoleate were efficiently incorporated into LDL with concentrations ranging between 2.7 to 16.9 isoflavone molecules/LDL particle, while much smaller amounts of unesterified isoflavones and genistein stearates were transferred into LDL. LDL containing 7-oleates or 4',7-dioleates of genistein and daidzein significantly reduced U937 cell proliferation by 36-43%. The strongest inhibitory effect was shown by daidzein 4',7-dilinoleate with 93% reduction of cell proliferation. Neither of the 4'-oleates of genistein and daidzein contained in LDLs exhibited antiproliferative effects although they were incorporated into LDL. In summary, we demonstrated that isoflavones made fat-soluble by esterification can be incorporated into LDL in vitro and delivered into cultured U937 cells via the LDL-receptor pathway, reducing the cell proliferation.
Meng
Q H
QH
Department of Medicine, Helsinki University Central Hospital, Finland.
Wähälä
K
K
Adlercreutz
H
H
Tikkanen
M J
MJ
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000138:chemical synthesis; D002455:Cell Division / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004337:Drug Carriers; D004952:Esters / Q000008:administration & dosage / Q000138:chemical synthesis; D006801:Humans; D007529:Isoflavones / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000493:pharmacokinetics / Q000494:pharmacology*; D008077:Lipoproteins, LDL / Q000008:administration & dosage* / Q000737:chemistry; D008081:Liposomes / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000494:pharmacology; D008517:Phytotherapy; D011973:Receptors, LDL / Q000378:metabolism; D013025:Glycine max / Q000737:chemistry*; D020298:U937 Cells
D000972:Antineoplastic Agents, Phytogenic; D004337:Drug Carriers; D004952:Esters; D007529:Isoflavones; D008077:Lipoproteins, LDL; D008081:Liposomes; D011973:Receptors, LDL